Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • demis001
    Member
    • Apr 2009
    • 10

    #1

    MISO compare two samples with replicate; RNA-SEQ

    How can I compare two samples of RNA-SEQ with biological replicate using MISO?

    Assuming, I have 10 biological replicates for control and 10 biological replicate for knockdown samples. How can modify the following line to read 10 MISO run under the control directory and 10 MISO run under knockdown directory and compare the two samples with biological replicate?

    python run_miso.py --compare-samples control/ knockdown/ comparisons/

    Thanks
    DD
  • bioliyezhang
    Member
    • Mar 2011
    • 19

    #2
    Originally posted by demis001 View Post
    How can I compare two samples of RNA-SEQ with biological replicate using MISO?

    Assuming, I have 10 biological replicates for control and 10 biological replicate for knockdown samples. How can modify the following line to read 10 MISO run under the control directory and 10 MISO run under knockdown directory and compare the two samples with biological replicate?

    python run_miso.py --compare-samples control/ knockdown/ comparisons/

    Thanks
    DD
    Hi, demis:

    I wonder whether you have figured out how to do that? I have the exactly the same question as you. Can you give me some idea if you know how to do it?
    Thanks a lot.

    Comment

    • Simon Anders
      Senior Member
      • Feb 2010
      • 995

      #3
      Has MISO been updated to now be able to handle biological replicates?

      The method presented in the Nature paper could not, which is a very severe limitation and and was one of reasons why we saw a need for a new method and developed DEXSeq (Anders, Reyes, Huber; Genome Res, 2012).

      Comment

      • bioliyezhang
        Member
        • Mar 2011
        • 19

        #4
        Originally posted by Simon Anders View Post
        Has MISO been updated to now be able to handle biological replicates?

        The method presented in the Nature paper could not, which is a very severe limitation and and was one of reasons why we saw a need for a new method and developed DEXSeq (Anders, Reyes, Huber; Genome Res, 2012).
        Hi, Simon:

        thanks. So far, I think the current version of MISO still does not handle biological replicates. I will try the DEXSeq.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:13 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Working...